![Martin Lange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Lange
Directeur Technique/Scientifique/R&D chez
NOVO NORDISK A/S
Profil
Martin Holst Lange is Director at Pharmacosmos A since 2023.
Dr. Lange is Chief Scientific Officer & Executive VP at Novo Nordisk A since 2002.
Formerly, Dr. Lange was Medical Director at Novo Nordisk, Inc. from 2006 to 2008.
Dr. Lange was Director at Beta Bionics, Inc. from 2017 to 2020.
Education includes two doctorates from the University of Copenhagen, conferred in 1997 and 2004.
Postes actifs de Martin Lange
| Sociétés | Poste | Début |
|---|---|---|
| NOVO NORDISK A/S | Directeur Technique/Scientifique/R&D | 07/08/2025 |
Pharmacosmos A/S
 Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Directeur/Membre du Conseil | 18/08/2023 |
Anciens postes connus de Martin Lange
| Sociétés | Poste | Fin |
|---|---|---|
| BETA BIONICS, INC. | Directeur/Membre du Conseil | 20/02/2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Directeur Technique/Scientifique/R&D | 01/01/2008 |
Formation de Martin Lange
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
